- These Engineered Cells Are Super Soldiers That Hunt Down Cancers
- Death by Stem Cell: Developing New Cancer Therapies
- Bacteria can be engineered to fight cancer in mice. Human trials are coming.
- Lung cancer pill cuts risk of death by half, says ‘thrilling’ study
- Should we abandon the idea that cancer is something to ‘fight’?
Khalid Shah engineers stem cells to deliver cancer therapeutics directly to tumors, thereby increasing their efficacy.
We’re crawling with microbes, and scientists want to use them to treat disease.
Taking the drug osimertinib once a day after surgery reduces chance of patients dying by 51%, trials show
A new therapy combines two big advances, CRISPR and CAR-T, to create personalized immune cells that seek and destroy specific cancers.
The FDA’s accelerated-approval process was designed to help people access life-saving drugs. But gaps in communication could mean that people are undergoing treatments known to be ineffective.
Is it time to abandon the century-old idea that cancer is best met with a ‘fight’ from patients and their doctors alike?
Kite’s CEO discusses the company’s CAR T-cell therapies and what it means to put patients first.
Intratumour genetic ancestry only infrequently affects gene expression traits and subclonal evolution in colorectal cancer, with most genetic intratumour variation having no detected phenotypic…
Most advanced-stage cancers mutate, resisting drugs meant to kill them. Now doctors are harnessing the principles of evolution to thwart that lethal adaptation.
A critical mass of medical knowledge could soon end the death threat of cancer, but politics stands in the way
How does Refind curate?
It’s a mix of human and algorithmic curation, following a number of steps:
- We monitor 10k+ sources and 1k+ thought leaders on hundreds of topics—publications, blogs, news sites, newsletters, Substack, Medium, Twitter, etc.
- In addition, our users save links from around the web using our Save buttons and our extensions.
- Our algorithm processes 100k+ new links every day and uses external signals to find the most relevant ones, focusing on timeless pieces.
- Our community of active users gets the most relevant links every day, tailored to their interests. They provide feedback via implicit and explicit signals: open, read, listen, share, mark as read, read later, «More/less like this», etc.
- Our algorithm uses these internal signals to refine the selection.
- In addition, we have expert curators who manually curate niche topics.
The result: lists of the best and most useful articles on hundreds of topics.
How does Refind detect «timeless» pieces?
We focus on pieces with long shelf-lives—not news. We determine «timelessness» via a number of metrics, for example, the consumption pattern of links over time.
How many sources does Refind monitor?
We monitor 10k+ content sources on hundreds of topics—publications, blogs, news sites, newsletters, Substack, Medium, Twitter, etc.
Can I submit a link?
Indirectly, by using Refind and saving links from outside (e.g., via our extensions).
How can I report a problem?
When you’re logged-in, you can flag any link via the «More» (...) menu. You can also report problems via email to email@example.com
Who uses Refind?
400k+ smart people start their day with Refind. To learn something new. To get inspired. To move forward. Our apps have a 4.9/5 rating.
Is Refind free?
Yes, it’s free!
How can I sign up?
Head over to our homepage and sign up by email or with your Twitter or Google account.